As political winds shift and the world enters into an age appreciative of medical cannabis, it’s critical to understand the effects this plant has on the human brain. Undeniably, cannabis impact...
In 2019, we published a piece exploring the correlation between increased access to medical cannabis and a decrease in opioid use. Two years is a long time when it comes to medical cannabis research, ...
In the RYAH Data ecosystem, approximately 42 percent of patients prefer sativa and sativa-dominant cultivars, while 44.2 percent prefer indica and indica-dominant strains. Under a scientific lens, do ...
Women’s health, a topic traditionally excluded from scientific research, is slowly getting more recognition. Menopause is one such condition getting renewed attention, including through the lens...
Between January 1, 2018, and November 1, 2020, there have been more than 9,000 sessions of patients consuming medical cannabis for obsessive-compulsive disorder (OCD) within the RYAH Data ecosystem. T...
For decades, the misunderstood relationship between cannabis and schizophrenia has sowed fear among regulators, healthcare providers, and law enforcement. Opposition to legalization has often come wra...
The world is in the midst of an unprecedented global pandemic. Governments, research centers, and international health organizations are throwing everything they have at finding a solution to the newl...
First it won over millennials. Then came the Baby Boomers. Now medical cannabis is piquing the interest of patients over the age of 65. Despite initial hesitations during the first wave of legalizatio...
The UK may have legalized medical cannabis in 2018, but that doesn’t mean patients can access it. According to a recent report in The Guardian, just two patients are receiving medical cannabis t...
The endocannabinoid theory of disease began with the discovery of the endocannabinoid system. Unlike the central nervous system, the respiratory system, and other essential systems which have been inv...
The European cannabis market is a much different beast than what has evolved across the pond in North America. If North America is about wild market predictions, high-risk investments, and murky regul...
Nearly a decade ago, a team of researchers hailing from the University of São Paulo, Brazil, worked with a group of 24 participants diagnosed with social anxiety disorder. Divided into groups, the pa...
The French are standing on the precipice of significant policy change. In the last year, France has made progressively confident legislative steps towards a medical cannabis program. In January 2020, ...
Cannabis for pediatric care? What initially may sound like a shocking and perhaps controversial subject is already a reality. In 2020, cannabis and the plant’s derivatives are well into preclini...
Whether national sports leagues are ready for the transition or not, cannabis is a growing component of sports medicine and athletic wellness. Players from across the sports spectrum are advocating fo...
On Monday, February 24, 2020, RYAH Medtech announced a brand new technology set to revolutionize the delivery of plant-based (and non-plant-based) medicines. The RYAH Smart Transdermal Patch is the fi...
Sleep is consistently one of the primary reasons why people turn to cannabis-based therapies. Within RYAH Data it’s the fifth most common ailment treated, no matter the demographic. This prefere...
Medicinal and recreational advocates have long loved the mildly sedative, sleep-promoting qualities of cannabis, but what does the research actually show us? Stoner stereotypes aside, cannabis has a l...
Based on the early reporting, there is a growing consensus that 2020 may not be the year the US government passes any significant cannabis legislation. Other, more attention-grabbing national headline...
In America, medical cannabis is an ever-changing legal landscape. With any major federal change likely a few years off, state policymakers have been busy creating unique, state-based programs to meet ...
Change is coming to the medical cannabis landscape in the US, but it’s not as rapid as many would hope. Bipartisan political blockades seem to be getting in the way of meaningful cannabis ref...
